The Effect of Ruboxistaurin on Small Fiber Function

Completed · Phase 2

Conditions studied: Diabetic Neuropathy

In brief

To determine the effect of Ruboxistaurin on small fiber function.

Key facts

Study ID

NCT00190970

Run by

Chromaderm, Inc.

People needed

52

Starts

2004-10-01

Expected to finish

2005-11-01

Last updated by the study team

2016-07-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have Type 1 or Type 2 diabetes mellitus
• Patients must have bilateral sensorimotor distal peripheral neuropathy attributable to diabetes mellitus
• Patients must have blood glucose control measured as HbA1c=<11%
• Patients must be 18 years of age or older.
• Patients must be able to return to all follow-up visits

You may not qualify if…

• Patients must not have symptoms of diabetic peripheral neuropathy that cannot be distinguished from other etiologies
• Patients must not have a neurologic disease or neuropathy from a cause other than diabetes mellitus that would interfere with correct evaluation of symptomatic peripheral neuropathy.
• Patient currently has uncontrolled high blood pressure
• You have other medical problems that your doctor feels would make it unsafe for you to participate in this study such as liver or kidney problems
• You are a woman of childbearing age and unwilling or unable to use effective contraceptive.

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.